Corrigendum to “Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)”
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Series: | EBioMedicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396423000518 |
| _version_ | 1828012341916073984 |
|---|---|
| author | Rosa De Miguel David Rial-Crestelo Lourdes Dominguez-Dominguez Rocío Montejano Andrés Esteban-Cantos Paula Aranguren-Rivas Natalia Stella-Ascariz Otilia Bisbal Laura Bermejo-Plaza Mónica Garcia-Alvarez Belén Alejos Asunción Hernando Mireia Santacreu-Guerrero Julen Cadiñanos Mario Mayoral Juan Miguel Castro Victoria Moreno Luz Martin-Carbonero Rafael Delgado Rafael Rubio Federico Pulido José Ramón Arribas |
| author_facet | Rosa De Miguel David Rial-Crestelo Lourdes Dominguez-Dominguez Rocío Montejano Andrés Esteban-Cantos Paula Aranguren-Rivas Natalia Stella-Ascariz Otilia Bisbal Laura Bermejo-Plaza Mónica Garcia-Alvarez Belén Alejos Asunción Hernando Mireia Santacreu-Guerrero Julen Cadiñanos Mario Mayoral Juan Miguel Castro Victoria Moreno Luz Martin-Carbonero Rafael Delgado Rafael Rubio Federico Pulido José Ramón Arribas |
| author_sort | Rosa De Miguel |
| collection | DOAJ |
| first_indexed | 2024-04-10T09:31:37Z |
| format | Article |
| id | doaj.art-157b0aa2989244dbb7f8f093c1273485 |
| institution | Directory Open Access Journal |
| issn | 2352-3964 |
| language | English |
| last_indexed | 2024-04-10T09:31:37Z |
| publishDate | 2023-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EBioMedicine |
| spelling | doaj.art-157b0aa2989244dbb7f8f093c12734852023-02-19T04:26:05ZengElsevierEBioMedicine2352-39642023-03-0189104486Corrigendum to “Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)”Rosa De Miguel0David Rial-Crestelo1Lourdes Dominguez-Dominguez2Rocío Montejano3Andrés Esteban-Cantos4Paula Aranguren-Rivas5Natalia Stella-Ascariz6Otilia Bisbal7Laura Bermejo-Plaza8Mónica Garcia-Alvarez9Belén Alejos10Asunción Hernando11Mireia Santacreu-Guerrero12Julen Cadiñanos13Mario Mayoral14Juan Miguel Castro15Victoria Moreno16Luz Martin-Carbonero17Rafael Delgado18Rafael Rubio19Federico Pulido20José Ramón Arribas21Hospital Universitario La Paz – IdiPAZ. Paseo de la Castellana 261, 28046, Madrid, SpainHospital Universitario 12 de Octubre - Imas12, Av. de Córdoba, s/n, 28041, Madrid, SpainHospital Universitario 12 de Octubre - Imas12, Av. de Córdoba, s/n, 28041, Madrid, SpainHospital Universitario La Paz – IdiPAZ. Paseo de la Castellana 261, 28046, Madrid, SpainHospital Universitario La Paz – IdiPAZ. Paseo de la Castellana 261, 28046, Madrid, SpainHospital Universitario 12 de Octubre - Imas12, Av. de Córdoba, s/n, 28041, Madrid, SpainHospital Universitario La Paz – IdiPAZ. Paseo de la Castellana 261, 28046, Madrid, SpainHospital Universitario 12 de Octubre - Imas12, Av. de Córdoba, s/n, 28041, Madrid, SpainHospital Universitario 12 de Octubre - Imas12, Av. de Córdoba, s/n, 28041, Madrid, SpainHospital Universitario 12 de Octubre - Imas12, Av. de Córdoba, s/n, 28041, Madrid, SpainInstituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029, Madrid, SpainUniversidad Europea de Madrid- Imas12, Calle Tajo, s/n, 28670 Villaviciosa de Odón, Madrid, SpainHospital Universitario 12 de Octubre - Imas12, Av. de Córdoba, s/n, 28041, Madrid, SpainHospital Universitario La Paz – IdiPAZ. Paseo de la Castellana 261, 28046, Madrid, SpainHospital Universitario La Paz – IdiPAZ. Paseo de la Castellana 261, 28046, Madrid, SpainHospital Universitario La Paz – IdiPAZ. Paseo de la Castellana 261, 28046, Madrid, SpainHospital Universitario La Paz – IdiPAZ. Paseo de la Castellana 261, 28046, Madrid, SpainHospital Universitario La Paz – IdiPAZ. Paseo de la Castellana 261, 28046, Madrid, SpainHospital Universitario 12 de Octubre - Imas12, Av. de Córdoba, s/n, 28041, Madrid, SpainHospital Universitario 12 de Octubre - Imas12, Av. de Córdoba, s/n, 28041, Madrid, SpainHospital Universitario 12 de Octubre - Imas12, Av. de Córdoba, s/n, 28041, Madrid, Spain; Corresponding author. Unidad VIH. Centro de Actividades Ambulatorias 2a Planta Bloque, D. Hospital 12 de Octubre. Av. Cordoba s/n. 28041-Madrid, Spain.Hospital Universitario La Paz – IdiPAZ. Paseo de la Castellana 261, 28046, Madrid, Spain; Corresponding author. Infectious Diseases Unit, Internal Medicine Service, Hospital La Paz, IdiPAZ, Castellana 261, 28046, Madrid, Spain.http://www.sciencedirect.com/science/article/pii/S2352396423000518 |
| spellingShingle | Rosa De Miguel David Rial-Crestelo Lourdes Dominguez-Dominguez Rocío Montejano Andrés Esteban-Cantos Paula Aranguren-Rivas Natalia Stella-Ascariz Otilia Bisbal Laura Bermejo-Plaza Mónica Garcia-Alvarez Belén Alejos Asunción Hernando Mireia Santacreu-Guerrero Julen Cadiñanos Mario Mayoral Juan Miguel Castro Victoria Moreno Luz Martin-Carbonero Rafael Delgado Rafael Rubio Federico Pulido José Ramón Arribas Corrigendum to “Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)” EBioMedicine |
| title | Corrigendum to “Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)” |
| title_full | Corrigendum to “Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)” |
| title_fullStr | Corrigendum to “Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)” |
| title_full_unstemmed | Corrigendum to “Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)” |
| title_short | Corrigendum to “Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)” |
| title_sort | corrigendum to dolutegravir plus lamivudine for maintenance of hiv viral suppression in adults with and without historical resistance to lamivudine 48 week results of a non randomized pilot clinical trial art pro |
| url | http://www.sciencedirect.com/science/article/pii/S2352396423000518 |
| work_keys_str_mv | AT rosademiguel corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT davidrialcrestelo corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT lourdesdominguezdominguez corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT rociomontejano corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT andresestebancantos corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT paulaarangurenrivas corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT nataliastellaascariz corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT otiliabisbal corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT laurabermejoplaza corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT monicagarciaalvarez corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT belenalejos corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT asuncionhernando corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT mireiasantacreuguerrero corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT julencadinanos corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT mariomayoral corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT juanmiguelcastro corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT victoriamoreno corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT luzmartincarbonero corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT rafaeldelgado corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT rafaelrubio corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT federicopulido corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro AT joseramonarribas corrigendumtodolutegravirpluslamivudineformaintenanceofhivviralsuppressioninadultswithandwithouthistoricalresistancetolamivudine48weekresultsofanonrandomizedpilotclinicaltrialartpro |